Junmaikang (adalimumab biosimilar) - Shanghai Junshi Biosci, Mabwell (Shanghai) Biosci, Binnopharm
https://www.prnewswire.com/news-releases/mabwells-adalimumab-biosimilar-receives-marketing-approval-in-indonesia-302651083.html
 
Dec 31, 2025
 
Next